同得仕(集團)(00518.HK)中期盈轉虧至3202.2萬港元
格隆匯11月26日丨 同得仕(集團)(00518.HK)公佈,截至2021年9月30日止6個月,公司收益2.32億港元,同比增加2.52%;公司擁有人應占淨虧3202.2萬港元,去年同期則錄得溢利2.4億港元,盈轉虧;每股淨虧7.1港仙。
儘管期間疫情持續帶來重重難關,集團仍錄得穩定營業額同比上升2.5%。對比去年同期,毛利率錄得輕微下降1.1個百分點。有關下降乃主要由於越南COVID-19疫情復燃導致我們的越南生產基地於2021年七月中旬至九月末暫停運作("越南工廠暫停運作")而短暫造成規模不經濟,以及期間將生產訂單從越南生產基地重新分配至中國中山生產基地的應急過程中產生的額外成及低效生產。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.